课题基金 / 基金详情

CLINICAL TRIAL: INHIBITING HISTONE DEACETYLASE: TOWARD ERADICATION OF HIV

CLINICAL TRIAL: INHIBITING HISTONE DEACETYLASE: TOWARD ERADICATION OF HIV
临床试验:抑制组蛋白脱乙酰酶:消灭艾滋病毒
批准号:
7716829
负责人:
DAVID MARGOLIS
金额:
$6.07万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-02 至 2008-05-31

项目摘要

项目成果

DAVID MARGOLIS的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 这项研究的目的是了解艾滋病毒感染有一天可能通过冲洗体内隐藏的病毒而治愈的可能性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to learn about the possibility that HIV infection may someday be cured by flushing out the hidden virus in the body.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APHERESIS PROCEDURES TO OBTAIN LEUKOCYTES FOR STUDIES FROM HIV NEGATIVE SUBJECTS
CHAVI 012 - MUCOSAL AND INNATE IMMUNE RESPONSES AND VIRAL RESERVOIRS IN TISSUES
10493 INTEGRASEVPA - MK-0518 INTENSIFICATION AND HDAC INHIBITION IN DEPLETION OF
CLINICAL TRIAL: RALTEGRAVIR (MK-0518), ON THE LEVEL OF PERSISTENT PLASMA VIREMIA